ReleaseWire Connect

India is the world's second largest producer of food next to China, and has the potential of being the biggest with the food and agricultural sector. Increasing incomes are always accompanied by a change in the food basket. The proportionate expenditure on milk and milk products, meat, egg and fish, fruits and beverages increases with rising income.

According to a new research report by RNCOS entitled, "Indian Ophthalmoscope Market Outlook 2020", increased eye-related issues along-with durability and clarity issues in domestically manufactured ophthalmoscope, have allowed Indian practitioners to demand for international brands. Enhanced awareness for eye-related disease and their procedures have fuelled the demand for ophthalmoscope in Tier1, Tier2 and Tier3 cities, across country. Increasing trend like getting rid of eye spectacle, opening various small eye-care clinics/centers across the country and medical insurance penetration has allowed the ophthalmoscope imports to jump seven times in last four years in India.

With a steep rise in infertility numbers in India, India's IVF market is expected to reach INR 38.2 Billion by 2020 end, registering a compound annual growth rate of 15%. Factors like burgeoned infertility numbers due to a major shift in lifestyle, delayed pregnancies and India emerging as a popular destination for medical tourism especially for IVF and surrogacy will allow the IVF market to grow substantially. Furthermore, India's IVF market being an unregulated industry has allowed many domestic and international players to join the race. In addition, mushrooming redirection IVF centers and procedure clinics with world-class facilities across India has led to greater visibility for IVF procedures, thus allowing greater footfall in IVF clinics/centers.

According to a new research report by RNCOS entitled, "Global Minimal Invasive Device Market Outlook 2020", the use of Minimally invasive devices provides immense benefits to patients such as reduction in trauma, blood-loss, scarring and post-operative pain for the patient, and considerable cost-savings due to shorter hospital stays, less post-surgical pain medication, faster recovery times, and reduced risks of postoperative complications. With numerous advantages over conventional treatment, MIS procedures have grown significantly and now impact almost all surgical specialties including endocrine, pediatric, bariatric, urologic, abdominal, gynecological, cardiothoracic, general, and orthopedics.

According to a new research report by RNCOS entitled, "Global Dermatology Device Market Outlook 2020", Asia is the third largest market in the skin care devices industry across worldwide. With the rising popularity of cosmetic procedures and skin problems among the population of Asian region, the demand for dermatology devices is rapidly rising. The countries in the Asian region which includes China and India have a tropical climate, which ultimately impacting the inhabitants of these regions as it leads to highly sun exposure especially skin tanning. This has bolstered the growth of dermatological treatment devices in the region.

According to a new research report by RNCOS entitled, "Global Influenza Vaccine Market Outlook 2020", US dominates the influenza vaccine market in the world and the emerging countries of Asia Pacific region is expected to capture a significant share in the Global Influenza Vaccine Market.

The much awaited biosimilars have finally entered the US pharmaceutical market with the FDA approval of Sandoz's Zarxio, a G-CSF. The move is expected to make US a significant region for biosimilar activity.

According to a new research report by RNCOS entitled, "US Generic Drug Market Outlook 2018", the United States devotes highest expenditure on healthcare as compared to any other Country globally. The US provides more health care in terms of more doctors' appointments, more surgery, more drugs, more diagnostic tests, longer stays in hospital than other countries. The region has considerably increased its healthcare expenditure from US$ 2,414 Billion to US$ 2,919 Billion in 2013. National Health expenditure in the US can be segmented as services provided by private sector and Government (public) share.

Recently, the Keck Medical Center of USC surgeons became the first in Southern California to perform the Food and Drug Administration-approved, robotic-assisted procedure for a lung cancer patient using the Da Vinci Xi robot, a minimally invasive surgical system. This increase in preference for minimally invasive device is expected to play a significant role in driving the growth of surgical robots.

Fuel Cell market is on the verge of becoming the new frontier with many companies already active in this space and many more start ups moving towards the new technology. Many auto manufacturers have been doing lot of research and development on hydrogen fuel-cell vehicles as the technology helps in producing zero-emission cars that have the potential to cut pollution and reduce the world's reliance on oil for transportation. Further, to speed up the fuel cell development, some of the automakers have decided to work together with other automakers, fuel cell companies and research institutions on the development of this technology. This will also bring down cost of producing fuel cells at a more affordable cost to customers. With this declining cost of fuel cells with increasing efficiency would bring a paradigm shift in the adoption of fuel cell technology.